Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Arch Bronconeumol
    August 2022
  1. COSIO BG, Shafiek H, Martinez-Garcia MA
    Is it Time to Readjust the Doses of Inhaled Corticosteroids in COPD?
    Arch Bronconeumol. 2022;58:593-594.
    >> Share

  2. ALCAZAR-NAVARRETE B, Diaz-Lopez JM, Garcia-Flores P, Ortega-Antelo M, et al
    T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:595-600.
    >> Share

  3. SU KC, Ko HK, Hsiao YH, Chou KT, et al
    Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Arch Bronconeumol. 2022;58:601-610.
    >> Share

  4. SORIANO JB, Dai X, Ancochea J
    An Euler Proportional Venn Diagram of Obstructive Lung Disease.
    Arch Bronconeumol. 2022;58:627-628.
    >> Share

    July 2022
  5. KUNADHARAJU R, Rudraraju A, Sethi S
    Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?
    Arch Bronconeumol. 2022;58:539-541.
    >> Share

    June 2022
  6. XU JF, Gao YH, Guan WJ
    Advances in Bronchiectasis Registries: The New Chinese Registry.
    Arch Bronconeumol. 2022 Jun 11. pii: S0300-2896(22)00447.
    >> Share

  7. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    >> Share

  8. LONG MB, Chalmers JD
    Treating Neutrophilic Inflammation in Airways Diseases.
    Arch Bronconeumol. 2022;58:463-465.
    >> Share

  9. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
    Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
    Arch Bronconeumol. 2022;58:517-519.
    >> Share

  10. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    >> Share

  11. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    >> Share

  12. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    >> Share

    May 2022
  13. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    >> Share

  14. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
    >> Share

  15. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    >> Share

  16. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    >> Share

  17. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    >> Share

  18. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    >> Share

  19. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    >> Share

  20. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    >> Share

  21. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    >> Share

  22. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    >> Share

  23. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    >> Share

  24. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    >> Share

  25. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    >> Share

  26. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    >> Share

  27. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    >> Share

  28. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    >> Share

  29. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    >> Share

    April 2022
  30. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    >> Share

  31. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    >> Share

  32. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    >> Share

  33. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    >> Share

  34. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    >> Share

  35. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    >> Share

  36. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    >> Share

  37. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    >> Share

  38. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    >> Share

  39. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    >> Share

  40. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    >> Share

  41. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    >> Share

  42. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    >> Share

    March 2022
  43. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    Asthma also exists in older people.
    Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
    >> Share

    February 2022
  44. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
    Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
    >> Share

  45. BARALDI F, Alfano F, Contoli M, Papi A, et al
    Small Airway Disease in Asthma: Why is it so Important?
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
    >> Share

  46. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    >> Share

  47. CAZZOLA M, Rogliani P, Matera MG
    The Future of Bronchodilators in COPD and Asthma.
    Arch Bronconeumol. 2022;58:107-108.
    >> Share

    January 2022
  48. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
    Arch Bronconeumol. 2022;58:35-51.
    >> Share

    December 2021
  49. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
    Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
    Arch Bronconeumol. 2021;57:739-740.
    >> Share

  50. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.
    >> Share

  51. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    >> Share

  52. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.
    >> Share

    November 2021
  53. OJANGUREN I, Satia I, Usmani OS
    The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
    Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
    >> Share

  54. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.
    >> Share

  55. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.
    >> Share

  56. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.
    >> Share

  57. MARTINEZ-GARCIA MA
    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.
    >> Share

    October 2021
  58. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.
    >> Share

  59. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    >> Share

  60. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.
    >> Share

  61. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.
    >> Share

  62. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    >> Share

    September 2021
  63. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
    Respiratory Physiotherapy and Bronchiectasis.
    Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
    >> Share

  64. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
    Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
    Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
    >> Share

  65. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.
    >> Share

  66. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.
    >> Share

  67. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.
    >> Share

  68. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    >> Share

  69. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    >> Share

  70. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    >> Share

    August 2021
  71. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    >> Share

  72. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    >> Share

  73. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.
    >> Share

    July 2021
  74. MCDONALD VM, Gibson PG
    Treatable Traits in Asthma and COPD.
    Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
    >> Share

  75. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    >> Share

    June 2021
  76. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
    Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
    Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
    >> Share

  77. HERRERO MARTIN S, Hueto Perez de Heredia J, Cuesta Remon A, Gomez Fernandez M, et al
    Is a mobile application useful for patients with moderate-severe asthma?
    Arch Bronconeumol. 2021 Jun 16. pii: S1579-2129(21)00188.
    >> Share

  78. BLANCO-APARICIO M, Calvo-Alvarez U, Gonzalez-Barcala FJ
    Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat.
    Arch Bronconeumol. 2021;57:383-384.
    >> Share

  79. CABRERA LOPEZ C, Gomez Saenz JT, Molina Paris J, Trigueros Carrero JA, et al
    Enabling a Community Approach to Respiratory Diseases: The HACER COPD Project.
    Arch Bronconeumol. 2021;57:442-444.
    >> Share

  80. GALERA R, Casitas R, Martinez-Ceron E, Rodriguez-Fraga O, et al
    Effect of Dynamic Hyperinflation on Cardiac Response to Exercise of Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2021;57:406-414.
    >> Share

  81. CABRERA LOPEZ C, Gomez Saenz JT, Molina Paris J, Trigueros Carrero JA, et al
    Enabling a Community Approach to Respiratory Diseases: The HACER COPD project.
    Arch Bronconeumol. 2021;57:442-444.
    >> Share

  82. GALERA R, Casitas R, Martinez-Ceron E, Rodriguez-Fraga O, et al
    Effect of Dynamic Hyperinflation on Cardiac Response to Exercise of Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2021;57:406-414.
    >> Share

    May 2021
  83. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.
    Arch Bronconeumol. 2021 May 26. pii: S0300-2896(21)00165.
    >> Share

    April 2021
  84. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
    Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
    Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
    >> Share

    March 2021
  85. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021 Mar 11. pii: S0300-2896(21)00094.
    >> Share

  86. HALPIN DMG, Vogelmeier CF, Agusti AA
    COPD & COVID-19.
    Arch Bronconeumol. 2021;57:162-164.
    >> Share

  87. SORIANO JB
    Reply to <>.
    Arch Bronconeumol. 2021;57:235.
    >> Share

  88. LOPEZ-CAMPOS JL, Alcazar Navarrete B
    COPD Diagnosis in EPI-SCAN II.
    Arch Bronconeumol. 2021;57:234.
    >> Share

    February 2021
  89. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021 Feb 17. pii: S0300-2896(21)00054.
    >> Share

    January 2021
  90. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D Supplementation: A Treatment With Possible Benefits in Asthma.
    Arch Bronconeumol. 2021 Jan 28. pii: S0300-2896(21)00027.
    >> Share

  91. GARCIA CLEMENTE M, Madrid Carbajal C, Iscar Urrutia M
    Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis.
    Arch Bronconeumol. 2021;57 Suppl 1:11-12.
    >> Share

  92. SALES AR, Casagrande EM, Hochhegger B, Zanetti G, et al
    The Reversed Halo Sign and COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding.
    Arch Bronconeumol. 2021;57 Suppl 1:73-75.
    >> Share

  93. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
    Arch Bronconeumol. 2021;57:13-14.
    >> Share

    December 2020
  94. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged Treatment With Inhaled Ampicillin in Children With Non-cystic Fibrosis Bronchiectasis.
    Arch Bronconeumol. 2020 Dec 25. pii: S0300-2896(20)30538.
    >> Share

  95. HERRERO MARTIN S, Hueto Perez de Heredia J, Cuesta Remon A, Gomez Fernandez M, et al
    Is a Mobile Application Useful for Patients with Moderate-Severe Asthma?
    Arch Bronconeumol. 2020 Dec 10. pii: S0300-2896(20)30529.
    >> Share

  96. FERNANDEZ-GARCIA S, Represas-Represas C, Ruano-Ravina A, Fernandez Villar A, et al
    Reply to "The Importance of Dependence in Global Assessment of Hospitalized Patient".
    Arch Bronconeumol. 2020;56:834-835.
    >> Share

  97. BRIONGOS-FIGUERO LS, Cobos Siles M, Gabella Martin M, Abadia Otero J, et al
    The Importance of Dependence in Global Assessment of Hospitalized Patient.
    Arch Bronconeumol. 2020;56:833-834.
    >> Share

    November 2020
  98. POSSO M, Comas M, Roman M, Domingo L, et al
    Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
    Arch Bronconeumol. 2020;56:756-758.
    >> Share

    October 2020
  99. PLAZA V, Blanco M, Garcia G, Korta J, et al
    Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0.
    Arch Bronconeumol. 2020 Oct 22. pii: S0300-2896(20)30383.
    >> Share

  100. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19.
    Arch Bronconeumol. 2020 Oct 22. pii: S0300-2896(20)30385.
    >> Share

    September 2020
  101. BLANCO-APARICIO M, Calvo-Alvarez U, Gonzalez-Barcala FJ
    Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat.
    Arch Bronconeumol. 2020 Sep 30. pii: S0300-2896(20)30302.
    >> Share

  102. TANG J, Ramis-Cabrer D, Curull V, Mateu-Jimenez M, et al
    Markers of Stroma in Lung Cancer: Influence of COPD.
    Arch Bronconeumol. 2020 Sep 24. pii: S0300-2896(20)30311.
    >> Share

  103. LOZANO J, Nafria B, Alsina L
    The Long Road to Biologic Therapies for Asthma in Pediatric Patients.
    Arch Bronconeumol. 2020 Sep 23. pii: S0300-2896(20)30282.
    >> Share

    July 2020
  104. PLAZA MORAL V, Gomez-Outes A, Quirce Gancedo S, Alobid I, et al
    Discrepancies Between GEMA and GINA in the Classification of Inhaled Corticosteroids.
    Arch Bronconeumol. 2020;56:472-473.
    >> Share

    May 2020
  105. DE-TORRES JP, Wisnivesky JP, Bastarrika G, Wilson DO, et al
    Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    Arch Bronconeumol. 2020 May 12. pii: S0300-2896(20)30104.
    >> Share

    February 2020
  106. MUNOZ-LUCAS MA, Jareno-Esteban J, Gutierrez-Ortega C, Lopez-Guijarro P, et al
    Influence of Chronic Obstructive Pulmonary Disease on Volatile Organic Compounds in Patients with Non-small Cell Lung Cancer.
    Arch Bronconeumol. 2020 Feb 10. pii: S0300-2896(20)30006.
    >> Share

    November 2019
  107. BLANCO I, Valeiro B, Torres-Castro R, Barberan-Garcia A, et al
    Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2019 Nov 23. pii: S0300-2896(19)30407.
    >> Share

    March 2019
  108. SEIJO LM, Peces-Barba G
    Inhaled Corticosteroids and Lung Cancer in COPD.
    Arch Bronconeumol. 2019 Mar 2. pii: S0300-2896(19)30068.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016